Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Platelet production from induced pluripotent stem cells.

Journal of thrombosis and haemostasis : JTH - 1 Sept 2017

Sugimoto N, Eto K

Abstract excerpt

Ex vivo production of human platelets has been pursued as an alternative measure to resolve limitations in the supply and safety of current platelet transfusion products. To this end, induced pluripotent stem cells (iPSCs) are considered an ideal global source, as they are not only pluripotent and self-renewing, but are also available from basically any person, have relatively few ethical issues, and are easy to...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bioreactors
Share to Blood Platelets
Share to Cell Culture Techniques

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Induced Pluripotent Stem Cells

Share to Platelet Transfusion

Share to Regenerative Medicine

Share to Thrombopoiesis

Share to Transfusion Reaction

Source

Identifiers

PMID: 28752663
DOI: 10.1111/jth.13736

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Platelet production from induced pluripotent stem cells.PMID 28752663Read ↗

Scalable Generation of Universal Platelets from Human Induced Pluripotent Stem CellsSemantic proximity Read ↗

Induced pluripotent stem cell–derived human platelets: one step closer to the clinicSemantic proximity Read ↗

Induced pluripotent stem cell–derived human platelets: one step closer to the clinicSemantic proximity Read ↗

Induced Pluripotent Stem Cell-Derived Megakaryocytes and Platelets for Disease Modeling and Future Clinical Applications.Semantic proximity Read ↗

Manipulating megakaryocytes to manufacture platelets ex vivo.Semantic proximity Read ↗

Large‐Scale Production of Transfusion‐Ready Red Blood Cells From Induced Pluripotent Stem CellsSemantic proximity Read ↗

Generation and characterization of HLA-universal platelets derived from induced pluripotent stem cellsSemantic proximity Read ↗

Ex vivo manufacturing of platelets: beyond the first-in-human clinical trial using autologous iPSC-plateletsSemantic proximity Read ↗

Generation of red blood cells from induced pluripotent stem cellsSemantic proximity Read ↗

Expandable Megakaryocyte Cell Lines Enable Clinically Applicable Generation of Platelets from Human Induced Pluripotent Stem CellsSemantic proximity Read ↗

Red blood cells from induced pluripotent stem cells: hurdles and developmentsSemantic proximity Read ↗

Generation of HLA-Universal iPSC-Derived Megakaryocytes and Platelets for Survival Under Refractoriness ConditionsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.